ClinicalTrials.Veeva

Menu

Analysis of Biomarkers From Patients With Chorioretinal Diseases

K

Kyungpook National University

Status

Enrolling

Conditions

Macular Degeneration
Diabetic Retinopathy

Treatments

Drug: Chorioretinal diseases

Study type

Observational

Funder types

Other

Identifiers

NCT02026843
KNUH2013-1

Details and patient eligibility

About

This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.

Full description

This prospective, case-control study included 50 patients(50eyes) with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration. and 50 patient with nondiabetic retinopathy or cataract. Ocular fluids and blood samples were taken before injection of anti-vascular endothelial growth factor agent or pars plana vitrectomy for other retinal disease. Ocular biomarkers were analyzed.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age over 20 years
  • patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
  • patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
  • control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.

Exclusion criteria

  • under the age of 20 years
  • patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
  • patients that did not signed the informed consent of the trial
  • patients with intraocular inflammations or infections that requiring any pharmaceutical agent
  • patients with recent ocular trauma

Trial design

100 participants in 2 patient groups

Chorioretinal diseases
Description:
chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
Treatment:
Drug: Chorioretinal diseases
Control
Description:
control patients with surgeries include pars plana vitrectomy of macular hole, epiretinal membrane, cataract surgery.

Trial contacts and locations

1

Loading...

Central trial contact

Dong Ho Park, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems